International randomised controlled trial evaluating metabolic syndrome in type 2 diabetic cigarette smokers following switching to combustion-free nicotine delivery systems: the DIASMOKE protocol

Institutions:

• Polish Academy of Sciences, Mossakowski Medical Research Centre Polish Academy of Sciences, Warsaw, Poland
• Department of Internal Diseases, Endocrinology and Diabetology, CK MSW, Warszawa, Poland
• Ashford and Saint Peter's Hospitals NHS Trust, Chertsey, Surrey, UK
• School of Clinical Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK
• JB Medical Ltd, Sudbury, Suffolk, UK
• Endocrinology, Nicolae Testemitanu State Medical and Pharmaceutical University, Chisinau, The Republic of Moldova
• U O C. MCAU, University Teaching Hospital 'Policlinico-Vittorio Emanuele', University of Catania, Catania, Italy
• Centro per la Prevenzione e Cura del Tabagismo (CPCT), Universita degli Studi di Catania Scuola di Facolta di Medicina, Catania, Italy
• Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Sicilia, Italy
• Department of Clinical and Experimental Medicine, University of Catania, Catania, Sicilia, Italy
• The University of Lahore University College of Medicine and Dentistry, Lahore, Pakistan
• Cardiology, Ashford and Saint Peter's Hospitals NHS Trust, Chertsey, Surrey, UK
• Mossakowski Medical Research Centre, Polska Akademia Nauk, Warszawa, Poland
• Institute of Cardiovascular Research, Royal Holloway University of London, Egham, Surrey, UK